NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche

Concepts

• england
• runcorn
• pharmaceutical products
• offer reference number
• nhs framework
• 03 - nhs national framework agreement
• 01 - nhs framework
• period of framework
• 02 - nhs framework
• annual tranche

Location

Geochart for 1 buyers and 0 suppliers

NHS England

+−

Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

Description

NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche. Offer reference number: CM/PHR/20/5606 CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Document No. 09 - Tender design and instructions on completing the offer schedule Document No. 09 - Tender design and instructions on completing the offer schedule.doc Document No. 10 - Participating Authorities Document No. 10 - Participating Authorities.xls Document No. 05c - Volume discounts or Additional Products Offer Schedule Document No. 05c - Volume discounts or Additional Products Offer Schedule.xls Document No. 05 - Selectt offer schedule instructions Document No. 05 - Selectt offer schedule instructions.docx Document No. 05a - Selectt Offer schedule - CM_PHR_20_5606_01 Document No. 05a - Selectt Offer schedule - CM_PHR_20_5606_01.xml Document No. 03 - Framework Agreement and Terms and Conditions Document No. 03 - Framework Agreement and Terms and Conditions.pdf Document No. 06 - Form of offer Document No. 06 - Form of offer.doc Document No. 07a - Quality control technical sheet Document No. 07a - Quality control technical sheet.doc Document No. 05a - Selectt Offer schedule - CM_PHR_20_5606_02 Document No. 05a - Selectt Offer schedule - CM_PHR_20_5606_02.xml Document No. 05a - Selectt Offer schedule - CM_PHR_20_5606_03 Document No. 05a - Selectt Offer schedule - CM_PHR_20_5606_03.xml Document No. 01 - Invitation to offer covering letter CM_PHR_20_5606 Document No. 01 - Invitation to offer covering letter CM_PHR_20_5606.docx Document No. 02 - Terms of offer Document No. 02 - Terms of offer.doc Document No. 05b - Tender Product listing and usage - CM_PHR_20_5606_02 Document No. 05b - Tender Product listing and usage - CM_PHR_20_5606_02.xlsx Document No. 05b - Tender Product listing and usage - CM_PHR_20_5606_03 Document No. 05b - Tender Product listing and usage - CM_PHR_20_5606_03.xlsx Document No. 04a - Quality Assurance Process Document No. 04a - Quality Assurance Process.pdf Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements.docx Document No. 05b - Tender Product listing and usage - CM_PHR_20_5606_01 Document No. 05b - Tender Product listing and usage - CM_PHR_20_5606_01.xlsx Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022 Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines - Edition 5.1 September 2022.pdf Document No. 08 - Confidential information schedule Document No. 08 - Confidential information schedule.xls